DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20160745

A comparative study of thyroid status of patients on phenytoin, carbamazepine and valproate monotherapy

Dinesh K. Dhodi, Sagar B. Bhagat, Ketaki C. Patil

Abstract


Background: Anti-epileptic drugs are well tolerated, many effects on endocrine function have been reported, especially, the effect of long-term administration of anticonvulsant drugs on blood thyroid hormone levels.

Methods: An analytical, cross sectional, non-randomized study conducted in Neurology Department over a period of twelve months from November 2012 to October 2013 where in 90 patients was enrolled in the study.

Results: Of the 90 patients 56 were male and 34 were females. Baseline evaluation of the thyroid status of all patients were noted and showed all the 90 patients were clinically and Para clinically euthyroid. Patients on Phenytoin showed serum TSH value (Mean ± SD) to be statistically higher than the baseline and the normal reference value, whereas no significant difference was noted in the serum free T3 and T4 values. When patients on carbamazepine were evaluated, statistically significant difference was noted in the serum T3 and T4 level and was found to be lower than the reference value. No significant difference was seen in the serum TSH level. Patients receiving valproate showed no significant difference in the serum T3, T4 and TSH before and 6 month after prescription. All the patients were clinically euthyroid and showed no sign and symptoms of hypothyroidism.

Conclusions: Valproate monotherapy does not alter serum levels of thyroid hormones. On the contrary, alterations of thyroid hormone function were seen in patients treated with carbamazepine and phenytoin. However, all the patients were euthyroid and were not associated with clinical or even subclinical hypothyroidism.


Keywords


Epilepsy, Thyroid function, Phenytoin, Carbamazepine, Valproate

Full Text:

PDF

References


Lowenstein DH. Seizures and epilepsy. In: Longo DL, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, Fauci AS, editors. Harrison's principles of internal medicine. 18thed. New York: McGraw Hill. 2011:3251-69.

Castro-Gago M, María Inés Novo-Rodríguez. Evolution of Subclinical Hypothyroidism in children treated with antiepilepticdrugs. Pediatric Nourology. 2007;37(6):426.

Alberto V, Melissa L, Alessandra S, Emilio F, Francesco C. Thyroid hormones in children with epilepsy during long-term administration of carbamazepine and valproate. European Journal of Endocrinology.(2009;160:81-86.

Ramsay I. Drug and non-thyroid induced changes in thyroid function tests. Postgrad Med J. 1985;61:375-7.

Connacher AA, Borsey DQ, Browning MCK, Davidson DLW, Jung RT. The effective evaluation of thyroid status in patients on phenytoin, carbamazepine or sodium valproate attending an epilepsy clinic. Postgraduate Medical Journal. 1987;63:841-5.

Oppenheimer JH, Fisher LV, Nelson KM, Jailer JW. Depresion of the serum protein bound iodine level by diphenylhydantoin. Clin Endocrinol Metab. 1961;2:252-62.

Surks MI, DeFesi CR. Normal serum free thyroid hormone concentrations in patients treated with phenytoin or carbamazepine. A paradox resolved. JAMA. 1996;275(19):1495-8.

Tiihonen M, Liewendahl K, Waltimo O, Ojala M, Välimäki M. Thyroid status of patients receiving long-term anticonvulsant therapy assessed by peripheral parameters: a placebo-controlled thyroxine therapy trial. Epilepsia. 1995;36(11):1118-25.

Betteridge T, Fink J. Phenytoin toxicity and thyroid dysfunction. N Z Med J. 2009;122(1303):102-4.

Collins RJ. Elevated thyroid-stimulating hormone in a 65-year-old patient with phenytoin toxicity. Consult Pharm. 2008;23(8):610-3.

Verrotti A, Basciani F, Morrresi S, Morgese G, Chiarelli F. Thyroid hormones in epileptic children receiving carbamazepine and valproic acid. Pediatric Neurology. 2001;25:43-6.

Isoja¨rvi JIT, Pakarinen AJ & Myllyla¨ VV. Thyroid function with antiepileptic drugs. Epilepsia. 1992;33:142-8.

Verrotti A, Laus M, Scardapane A, Franzoni E, Chiarelli F. Thyroid hormones in children with epilepsy during long-term administration of carbamazepine and valproate. Eur J Endocrinol. 2009;160(1):81-6.

Simko J, Horacek J. Carbamazepine and risk of hypothyroidism: a prospective study. Acta Neurol Scand. 2007;116(5):317-21.

Zhu S, Liu X, Ruan X, Cai Z. Changes of thyroid hormone levels in epileptic patients. Journal of Tongji Medical University. 1994;14:119-23.

http://www.globalrph.com/labs_t.htm.sited on July 10. 2014.

Yeo PPB, Bates D, Howe JG. Anticonvulsants and thyroid function. Br Med J. 1978;1:1581-3.

Molholm HJ, Skovsted L, Lauridsen UB, Kirkegaard C, Siersback-Nielsen K. The effect of diphenylhydantoin on thyroid function. J Clin Endocrinol Metab. 1974;39:785-9.

Rousso I, Pharmakiotis A, Gatzola M, Karatza E, Sklavounou-Tsouroutsoglou S. Effects of phenobarbital, diphenylhydantoin and carbamazepine on thyroid function in epileptic children. Acta Endocrinol. 1984;265:48-49.

Isoja¨rvi JIT, Pakarinen AJ, Myllyla¨ VV. Thyroid function with antiepileptic drugs. Epilepsia. 1992;33:142-8.

Cannacher AA, Borsey DQ, Browning MC, Davidson DL, Jung RT. The effective evaluation of thyroid status in patients on phenytoin, carbamazepine or sodium valproate attending an epilepsy clinic. Journal of Postgraduate Medicine. 1987;63:831-51.

Haidukewych D, Rodin EA. Chronic antiepileptic drugs therapy:classification by medication regimen and incidence of decreases in serum thyroxine and free thyroxine index. Therapeutic Drug Monitoring. 1987;9:392-8.

Ericsson UB, Bjerre I, Forsgren M, Ivarsson SA. Thyroglobulin and thyroid hormones in patients on long-term treatment with phenytoin, carbamazepine, and valproic acid. Epilepsia. 1985;26:594-6.

Isoja¨rvi JIT, Pakarinen AJ, MyllyIa¨ VV. Thyroid function in epileptic patients treated with carbarmazepine. Archives of Neurology. 1989;46:1175-8.

Tiihonen M, Liewendahl K, Waltimo O, Ojala M, Valimaki M. Thyroid status of patients receiving long-term anticonvulsant therapy assessed by peripheral parameters: a placebo-controlled thyroxine therapy trial. Epilepsia. 1995;36:810-6.

Surks MI, DeFesi CR. Normal serum free thyroid hormone concentrations in patients treated with phenytoin or carbamazepine. Journal of the American Medical Association. 1996;275:1495-8.

Bentsen KD, Gram L, Veje A. Serum thyroid hormones and blood folic acid during monotherapy with carbarmazepine or valproate. Acta Neurologica Scandinavica. 1983;67;235-41.

Isoja¨rvi JIT, Airaksinen KEJ, Mustonen JN, Pakarinen AJ, Rautio A, Pelkonen O, et al. Thyroid and myocardial function after replacing carbamazepine by oxcarbazepine. Epilepsia. 1995;36810-6.

Tanaka K, Koda Ma S, Yokoyama S, Komatsu M, Konishi H, Momota K, et al. Thyroid function in children with long term anticonvulsant treatment. Journal of Pediatric Neurosciences. 1987;13:90-4.

Fichsel H, Knopfle G. Effects of anticonvulsant drugs on thyroid hormones in epileptic children. Epilepsia. 1978;19:323-36.

Liewendahl K, Majuri H, Helenius T. Thyroid function tests in patients on long-term treatment with various anticonvulsant drugs. Clin Endocrinol. 1978;8:185-91.

Bentsen KD, Gram L, Veje A. Serum thyroid hormones and blood folic acid during monotherapy with carbamazepine or valproate. Acta Neurol Scand. 1983;67:235-41.

Vainionpa¨a¨ LK, Mikkonen K, Ra¨ttya¨ J, Knip M, Pakarinen AJ, Myllyla¨ VV et al. Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication. Epilepsia. 2004;45:197-203.

Cansu A, Serdarog˘lu A, C¸amurdan O, Hirfano¨glu T, Bideci A, Gu¨cu¨yener K. The evaluation of thyroid function, thyroid antibodies, and thyroid volumes in children with epilepsy during short-term administration of oxcarbazepine and valproate. Epilepsia. 2007;47:1855-9.

Perucca E, Hedges A, Makki KA, Ruprah M, Wilson JF, Richens AA. Comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients. Br J Clin Pharmacol. 1984;18:401-10.